Skip to main content

Lancet study finds no significant clinical benefits of antiviral drug remdesivir

Treatment with antiviral drug remdesivir may not significantly speed up recovery from COVID-19 in critically ill hospitalised patients compared to placebo, according to the first randomised trial of its kind published in The Lancet journal. The study led by researchers from China-Japan Friendship Hospital and Capital Medical University in China involved 237 adults aged 18 and older from ten hospitals in Wuhan.

from IndiaTV World: Google News Feed https://ift.tt/2yVKAIp

Comments

Popular posts from this blog

Singapore: Drunk Indian man jailed for assaulting police officer

A 25-year-old Indian national faces jail time after he was charged by a court in Singapore with attempting to assault a police officer and causing annoyance to the public while being drunk.  from IndiaTV World: Google News Feed http://bit.ly/2WunrCJ

Theresa May prepares for fresh talks with EU leaders

British Prime Minister Theresa May is to return to Brussels within days to meet European Union (EU) officials in a bid to rescue her Brexit deal. from IndiaTV World: Google News Feed http://bit.ly/2STc2P7

The best affordable robot vacuum is finally under $200 again

This robot vacuum gives the best bang for your buck cleaning-wise and is even more affordable for a limited time.             from USATODAY - Tech Top Stories https://ift.tt/2oyxlIt